Aigues-Vives, France

Isabelle Catherine Batxelli

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Isabelle Catherine Batxelli: Innovator in Hepatic Fibrosis Research

Introduction

Isabelle Catherine Batxelli is a prominent inventor based in Aigues-Vives, France. She has made significant contributions to the field of medical research, particularly in the detection and evaluation of hepatic fibrosis. With a total of five patents to her name, her work has the potential to impact the lives of many patients suffering from liver diseases.

Latest Patents

Among her latest patents, Batxelli has developed a combination of biomarkers for detecting and evaluating hepatic fibrosis. This application focuses on methods for determining the stage of hepatic tissue damage, specifically the hepatic fibrosis score in subjects infected with one or more hepatitis viruses. The invention involves measuring the levels of expression of selected genes, which are crucial for assessing the condition. Another notable patent is related to the synergistic combination of biomarkers for detecting and assessing hepatic fibrosis in patients suffering from chronic hepatitis. This application provides innovative methods for determining whether the stage of hepatic fibrosis has exceeded light fibrosis, utilizing biomarkers such as the CXCL10 protein and hyaluronic acid (HA).

Career Highlights

Throughout her career, Batxelli has worked with notable organizations, including Ariana Pharmaceuticals and the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale). Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Isabelle has collaborated with esteemed colleagues such as Tarik Asselah and Ivan Bieche. These partnerships have further enhanced her research and innovation in the medical field.

Conclusion

Isabelle Catherine Batxelli is a trailblazer in the realm of hepatic fibrosis research, with her innovative patents paving the way for improved diagnostic methods. Her contributions are vital for advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…